A phase I trial of the safety, tolerance, and pharmacokinetics of oral nelfinavir (Viracept) co-administered with zidovudine (ZDV) and lamivudine (3TC) in HIV infected pregnant women and their infants
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2012
At a glance
- Drugs Lamivudine/zidovudine (Primary) ; Nelfinavir (Primary) ; Lamivudine; Zidovudine
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 22 Oct 2005 New trial record.